Navigation Links
6,000 Turkeys Slaughtered at Czech Bird Flu Farm

Six thousand turkeys at a Czech farm where the potentially lethal H5N1 strain of bird flu was confirmed this week have been slaughtered, officials said on Friday.

"All the turkeys on the farm have been killed and the process is underway for the smaller flocks in the area, around 1,000 birds in all," Czech veterinary services spokesman Zbynek Semerad told AFP.

"That should be completed today (Friday)," he added.

The H5N1 strain of bird flu was confirmed on Thursday at the Tisova farm, in the centre of the country, the first time it has been detected in Czech domestic poultry.

Previous cases of bird flu in the Czech Republic have only affected wild swans.

Czech authorities have imposed a security cordon around the affected farm where disinfection work was continuing on Friday with the help of the army and emergency services.

While Czech authorities remain optimistic that the outbreak will not hit poultry exports, Russia announced Thursday that steps to ban Czech birds, meat, eggs and equipment connected to the poultry industry would be taken within "two to three days".

Czech Agriculture Minister Petr Gandalovic reacted to the threatened Russian ban during a visit to Tisova on Friday.

"It is not possible that international trade is stopped," he said, adding that Prague would seek bilateral negotiations with Moscow with the EU also acting as an intermediary.


'"/>




Page: 1

Related medicine news :

1. Outpatient List Falls From 41,000 To 6,000
2. Pre Implantation Genetic Haplotyping to Identify 6,000 Inherited Diseases
3. Islamabad Culls Over 6,000 Birds Control Bird-flu Outbreak
4. Ham And Turkeys Recalled From Honeybaked Food Company Due To Listeria Scare
5. Hundreds of Turkeys Die Due to Bird Flu
6. Hungarian Geese Slaughtered as Bird Flu Returns to EU
7. Czech Republic struck by fifth bird flu incident
8. H5N1 Bird Flu Confirmed at Czech Turkey Farm
Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Turkeys Slaughtered Czech Bird Flu Farm

(Date:12/2/2008)... , Amsterdam, 2 December 2008 - Elsevier announce...tters 2008 Supplement on the theme of "Second tri.... Second trimester abortion raises complex issues...providers of service delivery and the sometimes co... This issue of Reproductive Health Matters grew ...
(Date:12/2/2008)... , , WASHINGTON -- A new report from the Institu...ents, duty hours and workloads to decrease the cha...nce the learning environment for these doctors in ...educing residents, work hours from the maximum ave...il for Graduate Medical Education (ACGME) in 2003,...
(Date:12/2/2008)... , , SAN DIEGO, Dec. 2 S...est-growing exercise program for new moms and thei...r in baby care for more than 40 years, has signed ... , The new partnership will strengthen the com...ers and moms. , , "We are thrilled to have ...
(Date:12/2/2008)... Randomized Comparator Study to Evaluate Efficacy... , , WOODCLIFF LAKE, N.J., Dec. 2 /PRNewswi...nounced that it plans to initiate the first clinic...citabine for injection) compared to Vidaza(R) (aza...ntermediate-2 or high-risk myelodysplastic syndrom...
Breaking Medicine News(10 mins):Health News:Elsevier announces the 2008 supplement of Reproductive Health Matters 2Health News:Revised hours and workloads for medical residents needed to prevent 2Health News:Revised hours and workloads for medical residents needed to prevent 3Health News:Stroller Strides(R) Signs Pampers(R) as Premier Sponsor for 2009 2Health News:Eisai Will Initiate First Head-to-Head Study Comparing Dacogen(R) (decitabine for injection) and Vidaza(R) (azacitidine) in Patients with Myelodysplastic Syndromes 2Health News:Eisai Will Initiate First Head-to-Head Study Comparing Dacogen(R) (decitabine for injection) and Vidaza(R) (azacitidine) in Patients with Myelodysplastic Syndromes 3
... of pharmacology; the number of people taking medi...e recent years. It is however to be noted that com...nsequences, including death. // Several medicatio...can interact or work against each other. Patients ...
...een witness to the death of more than half a milli...e south of Russia.// According to the Federal Con... Jan 25 and Feb 1, almost 350,000 birds have died ...akhkent district, and 76,000 at the Makhachkalinsk...
... effective solutions to major problems. This is es...s now been found that addition of white vinegar to...ively destroy bacterial spores. // Researchers fr... this simple yet significant solution to bacterial...
...tution has warned about the possibility of a hemag... constitution of the much-dreaded avian influenza ...could enable human-human bird flu transmission by ...an receptors. The company has also alerted the WH...
Other Medicine News:Health News:Drug Combinations Could Be Dangerous 2Health News:Genetic Change In The H5N1 Virus Likely: Recombinomics Inc. 2
(Date:12/1/2008)... Dec. 1 GeoVax Labs, Inc...otechnology company developing,human vaccines for...Virus) and,other infectious agents, announced tod...Trials will take place in twelve sites across Nort...n collaboration with The National Institutes of,H...
(Date:11/28/2008)...OLIS, Nov. 28 Eli Lilly ...lemental New Drug Application (sNDA) from,the U.S...R) (duloxetine HCl),for the management of chronic...,the first half of 2009, adding data from a recent...itis pain of the knee. , The decision does ...
(Date:11/25/2008)...awareness can improve recovery , , Audio an...available on the Mayo Clinic News Blog. Please see... , ROCHESTER, Minn., Nov. 25 /PRNewswire-USNew...stroke patients don,t think they,re having a strok...til their condition worsens. The findings appear i...
(Date:11/25/2008)...E, Calif., Nov. 25 Pharm...that the company has completed a Phase 1,clinical...in-class,small-molecule Factor VIIa inhibitor. Th...unteers to evaluate the safety and pharmacologic e...I-27483 resulted in a linear dose,response in the...
Breaking Medicine Technology:GeoVax's Phase 2a HIV/AIDS Vaccine Human Trials to Begin in North and South America 2GeoVax's Phase 2a HIV/AIDS Vaccine Human Trials to Begin in North and South America 3Lilly Withdraws Application for Additional U.S. Indication for Cymbalta(R) for Chronic Pain 2Lilly Withdraws Application for Additional U.S. Indication for Cymbalta(R) for Chronic Pain 3Lilly Withdraws Application for Additional U.S. Indication for Cymbalta(R) for Chronic Pain 4Do You Know You're Having a Stroke? 2Do You Know You're Having a Stroke? 3Pharmacyclics Announces Completion of Phase 1 Clinical Trial of Factor VIIa Inhibitor PCI-27483 2Pharmacyclics Announces Completion of Phase 1 Clinical Trial of Factor VIIa Inhibitor PCI-27483 3Pharmacyclics Announces Completion of Phase 1 Clinical Trial of Factor VIIa Inhibitor PCI-27483 4Bioheart Founder Howard J Leonhardt Becomes Chairman of the Board of Directors 4022 1Bioheart Founder Howard J Leonhardt Becomes Chairman of the Board of Directors 4022 2Bioheart Founder Howard J Leonhardt Becomes Chairman of the Board of Directors 4022 3Bioheart Founder Howard J Leonhardt Becomes Chairman of the Board of Directors 4022 4NASA satellite measures pollution from east Asia to North America 2532 1NASA satellite measures pollution from east Asia to North America 2532 2NASA satellite measures pollution from east Asia to North America 2532 3Evanston Northwestern Healthcare Researchers Explain Effects of Large Scale Universal MRSA Surveillance Program That Supports Expanded Intervention 1543 1Evanston Northwestern Healthcare Researchers Explain Effects of Large Scale Universal MRSA Surveillance Program That Supports Expanded Intervention 1543 2Evanston Northwestern Healthcare Researchers Explain Effects of Large Scale Universal MRSA Surveillance Program That Supports Expanded Intervention 1543 3Emisphere Technologies Inc Announces 2007 Fourth Quarter and Year End Financial Results 4020 1Emisphere Technologies Inc Announces 2007 Fourth Quarter and Year End Financial Results 4020 2Emisphere Technologies Inc Announces 2007 Fourth Quarter and Year End Financial Results 4020 3Emisphere Technologies Inc Announces 2007 Fourth Quarter and Year End Financial Results 4020 4Emisphere Technologies Inc Announces 2007 Fourth Quarter and Year End Financial Results 4020 5Emisphere Technologies Inc Announces 2007 Fourth Quarter and Year End Financial Results 4020 6Emisphere Technologies Inc Announces 2007 Fourth Quarter and Year End Financial Results 4020 7Emisphere Technologies Inc Announces 2007 Fourth Quarter and Year End Financial Results 4020 8
... Reported Safety & Tolerability Profile,in Sub...CHICAGO, June 25 /PRNewswire-FirstCall/ -- Phase I...of the American Diabetes,Association demonstrated ...dase-4 (DPP-4) in development by Bristol-Myers,Squ...), in,combination with metformin, exhibited a stat...
...Unique Mechanism of Action and Broad Potential for...A, Calif., June 26, 2007 (PRIME NEWSWIRE) -- Avige... innovating therapeutics,for the treatment of neur...pinion on Investigational Drugs has published an a...(ibudilast), a potential,first-in-class, non-opioi...
Other Medicine Technology:Data Demonstrated Saxagliptin Added to Metformin Improved Glycemic,Control in Subjects with Type 2 Diabetes Compared to Metformin,Alone 2Data Demonstrated Saxagliptin Added to Metformin Improved Glycemic,Control in Subjects with Type 2 Diabetes Compared to Metformin,Alone 3Data Demonstrated Saxagliptin Added to Metformin Improved Glycemic,Control in Subjects with Type 2 Diabetes Compared to Metformin,Alone 4Data Demonstrated Saxagliptin Added to Metformin Improved Glycemic,Control in Subjects with Type 2 Diabetes Compared to Metformin,Alone 5Data Demonstrated Saxagliptin Added to Metformin Improved Glycemic,Control in Subjects with Type 2 Diabetes Compared to Metformin,Alone 6Expert Opinion Highlights Avigen's AV411 as Potential New,Therapeutic for Neuropathic Pain and Opioid Withdrawal 2Expert Opinion Highlights Avigen's AV411 as Potential New,Therapeutic for Neuropathic Pain and Opioid Withdrawal 3Expert Opinion Highlights Avigen's AV411 as Potential New,Therapeutic for Neuropathic Pain and Opioid Withdrawal 4Expert Opinion Highlights Avigen's AV411 as Potential New,Therapeutic for Neuropathic Pain and Opioid Withdrawal 5
Indicated for treatment of patella instability
OmoTrain is a unique support for the shoulder that promotes mobility and limits rotation.
... someone suffers an episode of acute low back pain...ickly restores functional mobility by providing po...,With just a few sizes that correspond directly to... will reduce inventory requirements while simplify...
Shoulder Immobilizer with Body Strap Navy blue cotton. Thumb look helps keep hand in neutral position. Padded, 2" blue pile material laminated to foam shoulder and body strap. Fits left or right. 5/p
Medicine Products: